RPM - Pharmaceutical

From Molecule to Market, Manage Every Milestone

We have built a framework for stage-gate project management using Critical Chain Project Management (CCPM) for R&D departments in generic pharmaceutical companies. It combines sequential go/kill/rework/redirect decision checkpoints with resource-constrained scheduling and buffer management, purpose-built for the parallel formulation, analytical, regulatory, and quality workstreams that define pharma development. A configurable gate model, with a default of seven gates, carries each product from concept and feasibility through formulation development, analytical method development, stability and scale-up, and regulatory filing (ANDA/DMF/CTD) to commercial launch, each gated by deliverable checklists and auditable sign-offs.

Task durations are stripped of individual safety margins and pooled into stage and project buffers, protecting the critical chain from the resource contention across formulation, analytical, regulatory, and QA teams that is unique to multi-product pharma pipelines. Most R&D delays are not caused by any single task running late, but by unmanaged resource conflicts and buffer erosion across the chain — CCPM makes that erosion visible before it becomes a missed filing or launch date.

CORE Platform features for Stage-Gate CCPM

The Stage-Gate CCPM platform digitizes the complete pharma R&D project lifecycle — from configurable stage and gate workflows to critical chain scheduling, buffer management, and portfolio reporting. It provides a structured, measurable, and traceable approach to product development while enabling continuous improvement across the development pipeline.

Stage-Gate & Governance

Configurable N-gate models with gate-specific deliverable checklists, reviewer-defined sign-off sequencing, go, kill, rework, and redirect decisions, and rejection reason codes. Version-controlled stage and gate definitions keep in-flight projects intact when WBS and SOPs change.

Critical Chain Scheduling

Identifies the critical chain through resource-constrained scheduling rather than the critical path alone, with CPM and CCPM views available at any time. Task-level median durations and ranges, plus full-kit readiness checks and relay-race execution, keep work moving without hand-off delays.

Buffer Management

Tracks stage and project buffers using fever charts with green and red zones per project and across the portfolio. Buffer penetration alerts automatically flag red-zone tasks to the R&D head so recovery action starts before delays reach the critical chain.

Sprint-Based Execution

Work runs one stage at a time. Stage activities start in a backlog, are divided into sprints, and carry a planned duration in days, planned effort in hours, and a material budget, each assigned to a specific person.

Budget, Hours & Material Tracking

Timesheets update hours across the system automatically, and budget-versus-actual variance is tracked for both hours and material by stage. Material requisitions and consumption are tagged to activities and integrated with SAP.

Templates & WBS Configuration

Stage and gate templates by product complexity and market, plus saved project templates covering cash flows, budget, activities, materials, and resources. The WBS of every stage and the acceptance criteria of every gate can be adjusted per project, with mandatory criteria where needed.

Cross-Functional Collaboration

Role-based task assignment across R&D, QA, QC, Regulatory, Manufacturing, Procurement, and Supply Chain. To-dos and issues carry due dates and owners and are tracked to closure, while project notes are summarized by AI.

Document & Master Data Management

Project documents are tagged with structured metadata such as product, gate, study type, and version for fast retrieval. Molecule, asset, facility, and item masters sit alongside, with available stock viewed from SAP.

Benefits of SG-CCPM

1. Protect Filing and Launch Dates, Not Just Task Dates

Manage the product pipeline through pooled buffers rather than individual task deadlines, catching delays before they hit the critical chain and push out a regulatory filing or launch.

2. Reduce Resource Contention

Plan capacity across formulation, analytical, regulatory, and QA teams and shared facilities for concurrent products, eliminating the multitasking that silently stalls development.

3. Standardize Go/Kill Decisions

Apply consistent gate checklists, sign-off workflows, and decision outcomes — go, kill, rework, or redirect — across products, portfolios, and sites, replacing ad hoc reviews with structured, auditable decisions.

4. Bridge R&D to Filing and Launch

Carry each product from formulation through ANDA, DMF, or CTD filing to commercial launch, with tagged project documents for fast retrieval and material requisitions and consumption integrated with SAP.

Book a Demo

Schedule a personalized demo with our team

Frequently Asked Questions

Everything you need to know about the SG-CCPM platform.

The platform is designed for R&D departments in generic pharmaceutical companies, where parallel workstreams such as API sourcing, formulation, analytical development, and regulatory preparation compete for shared teams and facilities, creating scheduling bottlenecks that standard project tools don't address.

CCPM identifies the true critical chain — accounting for both technical dependencies and resource contention — then protects it using pooled stage and project buffers instead of task-level padding, removing the Parkinson's Law delays and multitasking losses common in pharma development.

Stage-gate provides the phase structure and go/kill/rework/redirect governance — concept through commercial launch — while CCPM manages scheduling and resourcing within and across stages, so gate decisions are backed by real buffer and resource data rather than optimistic task estimates.

Buffers are visualized using fever charts with green and red zones for each project and across the portfolio. Buffer penetration alerts automatically flag red-zone tasks to the R&D head so recovery action can begin early.

The platform supports resource capacity planning across formulation, analytical, regulatory, and QA teams. Every activity is assigned to a specific person with planned duration, effort, and material budget, and assignees see their work in the project dashboard and activity tab, with timesheets updating hours across the system.

Yes. Stage and gate templates can be set up by product complexity — such as simple oral solids versus complex injectables or biosimilars — and by market, including US ANDA, EU, rest of world, and domestic. Projects can be saved to and loaded from templates, and the WBS and gate criteria can still be adjusted for each project.

The solution provides dashboards for projects by stage and gate, portfolio view, stage-wise Gantt timelines, budget variance in hours and material, buffer usage by stage, project analytics, and NPV analysis, plus milestone and launch-date reporting for management.

Yes. Material requisitions and consumption can be tagged to project activities and integrated with SAP, and item inventory screens show updated available stock from SAP.

Yes. The platform supports single-product projects as well as multi-site, multi-business-unit pharma R&D portfolios, with configurable workflows, role-based access control, granular permissions, and an escalation matrix for overdue and delayed items.